Watson David O. Insider Trading
Get the latest insider transactions of Watson David O.. Watson David O. is General Counsel in Apellis Pharmaceuticals, Inc. ($APLS). Discover the current value of Watson David O. shares.
Address: C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD 40014KY
Watson David O. is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | General Counsel | 96,772 |
Insider Trading Transactions of Watson David O.
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 4.31 | 978 | 4,215 | 96,772 |
Mar 23 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 4.31 | 978 | 4,215 | 2,421 |
Feb 11 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 47.72 | 468 | 22,333 | 95,794 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 0.00 | 7,500 | 0 | 94,387 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 0.00 | 1,875 | 0 | 96,262 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 44.90 | 45,000 | 2,020,500 | 45,000 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 44.90 | 11,250 | 505,125 | 11,250 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 0.00 | 7,500 | 0 | 94,387 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 0.00 | 1,875 | 0 | 96,262 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 44.90 | 45,000 | 2,020,500 | 45,000 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 44.90 | 11,250 | 505,125 | 11,250 |
Jan 29 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 3.76 | 23,441 | 88,138 | 66,845 |
Jan 29 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 4.31 | 20,042 | 86,381 | 86,887 |
Jan 29 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 3.76 | 23,441 | 88,138 | 0 |
Jan 29 2021 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 4.31 | 20,042 | 86,381 | 3,399 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 13.85 | 9,935 | 137,600 | 53,339 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 50.00 | 9,935 | 496,750 | 43,404 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 13.85 | 8,398 | 116,312 | 51,802 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 50.61 | 2,709 | 137,094 | 49,093 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 51.32 | 2,526 | 129,624 | 46,567 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 52.73 | 1,163 | 61,322 | 45,404 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 53.86 | 900 | 48,475 | 44,504 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 55.00 | 900 | 49,501 | 43,604 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 55.91 | 200 | 11,182 | 43,404 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 13.85 | 9,935 | 137,600 | 30,065 |
Dec 15 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 13.85 | 8,398 | 116,312 | 21,667 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 0.00 | 6,375 | 0 | 40,417 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 44.50 | 5,000 | 222,500 | 35,417 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 2.67 | 7,505 | 20,038 | 42,922 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 44.33 | 38,250 | 1,695,623 | 38,250 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 2.67 | 7,505 | 20,038 | 0 |
Jan 28 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 40.47 | 3,000 | 121,401 | 19,042 |
Jan 28 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 2.67 | 15,000 | 40,050 | 34,042 |
Jan 28 2020 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 2.67 | 15,000 | 40,050 | 7,505 |
Aug 09 2019 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 2.67 | 5,000 | 13,350 | 22,042 |
Aug 09 2019 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 2.67 | 5,000 | 13,350 | 22,505 |
Sep 17 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 2.67 | 32,818 | 87,624 | 32,818 |
Sep 17 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 18.78 | 15,776 | 296,336 | 17,042 |
Sep 17 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 2.67 | 32,818 | 87,624 | 27,505 |
May 30 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 2.67 | 624 | 1,666 | 624 |
May 30 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Buy | 2.67 | 624 | 1,666 | 624 |
May 30 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 0.00 | 624 | 0 | 0 |
May 30 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Sell | 0.00 | 624 | 0 | 0 |
May 30 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 2.67 | 624 | 1,666 | 60,323 |
May 30 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 2.67 | 624 | 1,666 | 60,323 |
Feb 21 2018 | APLS | Apellis Pharmaceuticals, ... | Watson David O. | General Counsel | Option Exercise | 14.95 | 25,000 | 373,750 | 25,000 |